Scpharmaceuticals Stock Price Prediction
| SCPH Stock | USD 3.28 0.14 4.09% |
Oversold Vs Overbought
53
Oversold | Overbought |
EPS Estimate Next Quarter (0.27) | EPS Estimate Current Year (1.78) | EPS Estimate Next Year (1.08) | Wall Street Target Price 17.5 | EPS Estimate Current Quarter (0.30) |
Using Scpharmaceuticals hype-based prediction, you can estimate the value of Scpharmaceuticals from the perspective of Scpharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Scpharmaceuticals using Scpharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Scpharmaceuticals using crowd psychology based on the activity and movement of Scpharmaceuticals' stock price.
Scpharmaceuticals Implied Volatility | 5.98 |
Scpharmaceuticals' implied volatility exposes the market's sentiment of Scpharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Scpharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Scpharmaceuticals stock will not fluctuate a lot when Scpharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Scpharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Scpharmaceuticals because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Scpharmaceuticals after-hype prediction price | USD 3.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Scpharmaceuticals |
Scpharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Scpharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Scpharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Scpharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Scpharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Scpharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Scpharmaceuticals' historical news coverage. Scpharmaceuticals' after-hype downside and upside margins for the prediction period are 0.16 and 6.87, respectively. We have considered Scpharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Scpharmaceuticals is risky at this time. Analysis and calculation of next after-hype price of Scpharmaceuticals is based on 3 months time horizon.
Scpharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Scpharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scpharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Scpharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.41 | 3.59 | 0.06 | 0.07 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.28 | 3.28 | 0.00 |
|
Scpharmaceuticals Hype Timeline
Scpharmaceuticals is at this time traded for 3.28. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of 0.07. Scpharmaceuticals is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.41%. %. The volatility of related hype on Scpharmaceuticals is about 1964.68%, with the expected price after the next announcement by competition of 3.35. About 82.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.95. Scpharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Scpharmaceuticals Basic Forecasting Models to cross-verify your projections.Scpharmaceuticals Related Hype Analysis
Having access to credible news sources related to Scpharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Scpharmaceuticals' future price movements. Getting to know how Scpharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Scpharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MIST | Milestone Pharmaceuticals | 0.01 | 5 per month | 2.96 | 0.13 | 7.43 | (6.08) | 20.63 | |
| ONCY | Oncolytics Biotech | (0.02) | 6 per month | 0.00 | (0.11) | 6.59 | (6.67) | 27.01 | |
| MCRB | Seres Therapeutics | 0.02 | 9 per month | 4.26 | (0.0003) | 10.00 | (6.78) | 28.84 | |
| LIFE | LIFE Old | 0.03 | 1 per month | 2.62 | 0.09 | 6.45 | (5.29) | 28.98 | |
| DMAC | DiaMedica Therapeutics | 0.05 | 5 per month | 3.79 | 0.09 | 8.64 | (5.65) | 47.69 | |
| LYRA | Lyra Therapeutics | (0.02) | 5 per month | 6.06 | (0) | 10.53 | (10.00) | 40.57 | |
| CNTA | Centessa Pharmaceuticals PLC | 0.85 | 10 per month | 0.00 | (0.03) | 6.30 | (6.19) | 15.71 | |
| SCPS | Scopus Biopharma | 0.00 | 0 per month | 12.41 | 0.01 | 33.33 | (23.33) | 56.67 | |
| MNPR | Monopar Therapeutics | 1.36 | 10 per month | 8.07 | 0.12 | 14.91 | (11.81) | 653.56 | |
| KTTA | Pasithea Therapeutics Corp | (0.18) | 3 per month | 0.00 | (0.20) | 7.39 | (8.42) | 17.34 | |
| IOVA | Iovance Biotherapeutics | (0.09) | 8 per month | 0.00 | (0.16) | 7.18 | (9.01) | 22.30 |
Scpharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Scpharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scpharmaceuticals using various technical indicators. When you analyze Scpharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Scpharmaceuticals Predictive Indicators
The successful prediction of Scpharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Scpharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Scpharmaceuticals based on analysis of Scpharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Scpharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Scpharmaceuticals's related companies. | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.95 | 0.86 | 0.9 | Days Of Inventory On Hand | 846.65 | 973.65 | 924.97 |
Story Coverage note for Scpharmaceuticals
The number of cover stories for Scpharmaceuticals depends on current market conditions and Scpharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Scpharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Scpharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Scpharmaceuticals Short Properties
Scpharmaceuticals' future price predictability will typically decrease when Scpharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Scpharmaceuticals often depends not only on the future outlook of the potential Scpharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scpharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.5 M | |
| Cash And Short Term Investments | 76 M |
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |